8
1
2
Cat. No. | Product Name | ||
---|---|---|---|
L2191 | 抗乳腺癌化合物库 | 1939 compounds | |
1939 种与乳腺癌相关的化合物,可以用于抗乳腺癌药物研发和药理研究; |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T60002 |
DC-S239
|
Histone Methyltransferase | Chromatin/Epigenetic |
DC-S239 (DC-S239) 是一种选择性的组蛋白甲基转移酶 SETD7 抑制剂 (IC50 = 4.59 μM),具有抗癌活性。 | |||
T10682L |
CARM1-IN-1
CARM1-IN-7G |
Histone Methyltransferase | Chromatin/Epigenetic |
CARM1-IN-1 (CARM1-IN-7G) 是 CARM1 的选择性抑制剂,IC50 为 8.6 μM。 CARM1-IN-1 对 PRMT1 和 SET7 的活性较弱,IC50 > 600 μM。 | |||
T16886 |
Sinefungin
Adenosyl-Ornithine,西奈芬净,A-9145,Antibiotic 32232RP |
Others; Histone Methyltransferase; Antibiotic; Antifungal | Chromatin/Epigenetic; Microbiology/Virology; Others |
Sinefungin (Adenosyl-Ornithine) 是病毒粒子mRNA (鸟嘌呤-7-)-甲基转移酶、 mRNA (核苷-2'-)-甲基转移酶和病毒增殖的有效抑制剂。它还抑制SET7/9,通过抑制H3K4甲基化来改善肾纤维化。 | |||
T64186 |
CARM1-IN-1 hydrochloride
|
Others | Others |
CARM1-IN-1 hydrochloride 是一种高效的、选择性的 CARM1 抑制剂 (IC50: 8.6 μM),对 PRMT1 和 SET7 抑制作用很低。 | |||
T71918 |
DC-S100
|
Others | Others |
DC-S100 is a selective histone methyltransferase SET7 inhibitor. | |||
T26188 |
Setin-1
|
Others | Others |
Setin-1 is the most potent Set7 inhibitor that acts by inhibiting the KMTase G9a. | |||
T68613 |
DC-S238
|
Others | Others |
DC-S238 is a potent and selective histone methyltransferase SET7 inhibitor. | |||
T72013 |
Epigenetic Multiple Ligand
|
Others | Others |
Epigenetic Multiple Ligand is a cell-permeable inhibitor of substrate processing by several chromatin-associated enzymes, including SIRT1/2, H3/SET7, H3/p300/CBP, H4/RmtA, PABP1/CARM1, and H4/PRMT1. It acts by inducing either apoptosis or granulocytic differentiation. |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01584 |
PR-Set7 Protein, Human, Recombinant
SET8,SET07,PR-Set7 |
Human | E. coli |
KMT5A (known as PR-Set7/9, SETD8 and SET8), a member of the SET domain containing methyltransferase family specifically targeting H4K20 for methylation, has been implicated in multiple biological processes. Inhibition of KMT5A attenuated proliferation and induced apoptosis. Elevated KMT5A expression was significantly correlated with extrathyroidal extension, lymph node metastasis and advanced pathological stage of papillary thyroid cancer. KMT5A may be a novel oncogenic factor, specifically a re... | |||
TMPY-01229 |
SETD7 Protein, Human, Recombinant (His)
SET7/9,SET domain containing (lys... |
Human | E. coli |
Histone-lysine N-methyltransferase SETD7, also known as SET domain containing (lysine methyltransferase) 7, SET7/9, Histone H3-K4 methyltransferase SETD7, H3-K4-HMTase SETD7, and SETD7, is a member of the histone-lysine methyltransferase family and SET7 subfamily. SETD7 is widely expressed and expressed in pancreatic islets. SETD7 contains three MORN repeats and one SET domain. SETD7 plays a central role in the transcriptional activation of genes such as collagenase or insulin. As a protein lysi... |